文献速递鼻科

鼻窦控制测试在慢性鼻窦炎术后疾病控制中的前瞻性多中心验证

Disease control after surgery for chronic rhinosinusitis: prospective, multi-institutional validation of the Sinus Control Test.
PubMed 文献 · Int Forum Allergy Rhinol · 2020-07-26

这项前瞻性多中心研究纳入218例接受内镜鼻窦手术的慢性鼻窦炎成人患者,术前和术后6个月分别使用鼻窦控制测试(SCT)评估疾病控制情况。SCT评分从8.9±3.5改善至4.3±3.7(p<0.001),且SCT变化与SNOT-22变化(r=0.500,p<0.001)及内镜评分变化(r=0.310,p<0.001)独立相关。

要点

  • SCT是一种4问题患者自报问卷,可用于评估慢性鼻窦炎术后疾病控制。
  • 术后SCT评分及控制状态分布均较术前显著改善。
  • SCT变化与SNOT-22及内镜评分变化相关,提供互补信息。

核心结论

  • 内镜鼻窦手术后SCT所测疾病控制改善与SNOT-22及内镜评分改善相关。
  • SCT是一种易于实施的工具,可提供与现有患者自报和客观严重度指标互补的信息。

研究设计与样本

  • 前瞻性多中心研究,从北美5个中心纳入接受内镜鼻窦手术的成人慢性鼻窦炎患者。
  • 共纳入218例患者,女性111例(50.9%),男性107例(49.1%),平均年龄50.1±15.6岁。
  • SCT在基线及术后6个月各施测一次,并使用SNOT-22和Lund-Kennedy内镜评分评估生活质量和疾病负担。
  • 采用线性回归分析特定人口学、合并症或疾病严重度指标是否与术后SCT评分变化独立相关。

主要发现

  • 平均SCT评分从术前8.9±3.5改善至术后4.3±3.7(p<0.001)。
  • 术前21.6%未控制、71.5%部分控制、6.9%控制;术后6.0%未控制、42.6%部分控制、51.4%控制(p<0.001)。
  • SCT评分变化与SNOT-22变化独立相关(r=0.500,p<0.001),与内镜评分变化独立相关(r=0.310,p<0.001)。
  • 在无鼻息肉的慢性鼻窦炎(CRSsNP)患者中,内镜评分与控制状态不相关,未控制与部分控制患者之间亦不相关。
  • 人口学特征和合并症与SCT变化无关。

临床怎么用

  • SCT可作为慢性鼻窦炎患者内镜鼻窦手术前后疾病控制的简易评估工具。
  • SCT结果应与SNOT-22及内镜评分结合解读,以全面评估疾病严重度。
  • 在无鼻息肉患者中解读内镜评分与控制状态关系时需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The Sinus Control Test (SCT) is a 4-question, patient-reported questionnaire that assesses disease control in chronic rhinosinusitis (CRS). This prospective, multicenter study examines SCT outcomes following endoscopic sinus surgery (ESS), further validating its use as a control instrument for CRS. METHODS: Adults with CRS undergoing ESS were prospectively enrolled from 5 centers across North America. The SCT was administered at baseline and once 6 months after surgery. Quality of life and disease burden were evaluated using the 22-item Sino-Nasal Outcome Test (SNOT-22) and Lund-Kennedy endoscopy scores. Linear regression was used to determine whether specific demographic, comorbidity, or disease severity measures were independently associated with changes in SCT scores postoperatively. RESULTS: A total of 218 patients, 111 females (50.9%) and 107 males (49.1%), were enrolled, with mean ± standard deviation age of 50.1 ± 15.6 years. Mean SCT score improved from 8.9 ± 3.5 to 4.3 ± 3.7 postoperatively (p < 0.001). Preoperatively, 21.6% were uncontrolled, 71.5% partially controlled, and 6.9% controlled. Postoperatively, 6.0% were uncontrolled, 42.6% partially controlled, and 51.4% controlled (p < 0.001). Change in SCT score correlated independently with change in SNOT-22 (r = 0.500, p < 0.001) and endoscopy scores (r = 0.310, p < 0.001). Endoscopy scores did not correlate with control status among patients with CRS without nasal polyposis (CRSsNP) nor between uncontrolled and partially controlled patients. Demographics and comorbidities were not associated with changes in SCT. CONCLUSION: Improvement in disease control following ESS as measured by the SCT correlated with improvements in SNOT-22 and endoscopy scores. The SCT is an easily administered instrument that provides information complementary to existing patient-reported and objective measures of disease severity.

来源:Int Forum Allergy Rhinol,查看原文。版权归原作者所有。

引用

  1. Little RE, Schlosser RJ, Smith TL, et al. Disease control after surgery for chronic rhinosinusitis: prospective, multi-institutional validation of the Sinus Control Test. Int Forum Allergy Rhinol. 2020. PMID: 32713106. doi:10.1002/alr.22659

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。